AMR Sept Banner v2

ASM Attends UN General Assembly

ASM President, Susan Sharp, Ph.D., joined global leaders at the United Nations General Assembly in New York today in a historical meeting to focus on the commitment to fight AMR.
Read

UN General Assembly Focuses on AMR

Leaders at the UN General Assembly draft a plan for coordinated, cross-cutting efforts to improve the current state of AMR.
Read

Superbugs are a 'Fundamental Threat'

If antibiotics were telephones, we would still be calling each other using clunky rotary dials and copper lines," Stefano Bertuzzi, CEO of ASM, told NBC News.
Read
Become a member today!
JOIN ASM
Submit Abstracts for Biothreats 2017
SUBMIT
Antibacterial Development Conference
REGISTER

andrews brenda


Dr. Andrews' current research interests include mechanisms of cell cycle control and the regulation of cell cycle-dependent transcription, kinase specificity and function, and regulation of cell polarity and morphogenesis.  Although her lab is particularly interested in these biological processes, they have a broader functional genomics program, based on an automated genetics platform that we developed in collaboration with the Boone laboratory.  Dr. Andrews' lab has established a unique array-based method for mapping genetic interaction networks in budding yeast called Synthetic Genetic Array or SGA analysis. The ultimate goal of their project is to generate a comprehensive genetic interaction network for a basic eukaryotic cell.  They have also expanded their automated yeast genetics to include a comprehensive study of second site suppressors and gene overexpression effects; this effort will be coupled with a new high through-put cell biology platform to allow phenotypic measurement on a large scale.  The lab's current large scale projects include genome-wide Synthetic Dosage Lethal screens to discover targets for protein kinases, and systematic assays of tagged reporter genes to delineate transcriptional regulatory pathways.

 

 

 

TPL_asm2013_SEARCH

91200